欢迎光临~北京凯森莱科技有限公司
语言选择: 中文版 ∷  英文版
  • 58994-96-0 , Ranimustine, Cymerin, MCNU,雷莫司汀, 雷诺氮芥, CAS:58994-96-0
  • 58994-96-0 , Ranimustine, Cymerin, MCNU,雷莫司汀, 雷诺氮芥, CAS:58994-96-0
58994-96-0 , Ranimustine, Cymerin, MCNU,雷莫司汀, 雷诺氮芥, CAS:58994-96-058994-96-0 , Ranimustine, Cymerin, MCNU,雷莫司汀, 雷诺氮芥, CAS:58994-96-0

58994-96-0 , Ranimustine, Cymerin, MCNU,雷莫司汀, 雷诺氮芥, CAS:58994-96-0

58994-96-0, Ranimustine,
Cymerin,
MCNU,
雷莫司汀,
雷诺氮芥,
CAS:58994-96-0
C10H18ClN3O7 / 327.719
MFCD00866369

 Ranimustine,Cymerin, MCNU, 雷莫司汀, 雷诺氮芥

Ranimustine is a chloroethylnitrosourea derivative that inhibits proliferation and growth of tumor cells by alkylation and cross-linkage of DNA strands of tumor cells. (NCI)

Ranimustine is an organic molecular entity.

Title: Ranimustine

CAS Registry Number: 58994-96-0

CAS Name: Methyl 6-[[[(2-chloroethyl)nitrosoamino]carbonyl]amino]-6-deoxy-a-D-glucopyranoside

Additional Names: methyl N-carbamyl-N'-(2-chloroethyl)-N'-nitroso-6-amino-6-deoxy-a-D-glucopyranoside; 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-a-D-glucopyranoside; 3-(methyl-a-D-glucopyranos-6-yl)-1-(2-chloroethyl)-1-nitrosourea; ranomustine; MCNU

Manufacturers' Codes: NSC-0270516

Trademarks: Cymerin (Tokyo Tanabe); Thymerin (Tokyo Tanabe)

Molecular Formula: C10H18ClN3O7

Molecular Weight: 327.72

Percent Composition: C 36.65%, H 5.54%, Cl 10.82%, N 12.82%, O 34.17%

Literature References: Chloroethylnitrosourea derivative with antitumor activity. Similar to carmustine, chlorozotocin, lomustine, nimustine, q.q.v. Prepn: NL 7507973; G. Kimura, J. Sekine, US 4057684; NL 7800920; G. Kimura, US 4156777 (1976, 1977, 1978, 1979, all to Tokyo Tanabe). Antitumor activity in rodents, comparison with other nitrosoureas: S. Sekido et al., Cancer Treat. Rep. 63, 961 (1979); S. Fujimoto, M. Ogawa, Cancer Chemother. Pharmacol. 9, 134 (1982); S. Fujimoto et al., Gann 75, 937 (1984). Mechanism of action: R. Kanamaru et al., Curr. Chemother. Immunother. 2, 1377 (1982). Effect of sugar alcohols on toxicity in mice: T. Tashiro et al., Cancer Chemother. Pharmacol. 8, 183 (1982). Series of articles on metabolic fate in rats: Y. Esumi et al., Iyakuhin Kenkyu 16, 381-428 (1985), C.A. 103, 115620q, 115621r, 134369f (1985). Clinical study in hematological malignant diseases: T. Masaoka et al., Chemotherapy (Tokyo) 33, 271 (1985).

Properties: Pale yellowish needles from anhydrous ethanol-ethyl ether (l:1), mp 111-112°. [a]D20 +93.2° (c = 0.5 in methanol) (Kimura). Also reported as 101-103° (dec) from isopropanol. [a]D25 +73.2° (c = 0.3 in methanol) (Kimura, Sekine). Solubility in water: 900 mg/ml at 25°. LD50 in male rats (mg/kg): 42 i.p., 42 i.v., 50 orally (Kimura).

Melting point: mp 111-112°

Optical Rotation: [a]D20 +93.2° (c = 0.5 in methanol) (Kimura); [a]D25 +73.2° (c = 0.3 in methanol) (Kimura, Sekine)

Toxicity data: LD50 in male rats (mg/kg): 42 i.p., 42 i.v., 50 orally (Kimura)

Therap-Cat: Antineoplastic.

Keywords: Antineoplastic; Alkylating Agents; Nitrosoureas.

CAS Number58994-96-0
Product NameRanimustine
IUPAC Name1-(2-chloroethyl)-1-nitroso-3-[(3,4,5-trihydroxy-6-methoxyoxan-2-yl)methyl]urea
Molecular FormulaC10H18ClN3O7
Molecular Weight327.72 g/mol
InChIInChI=1S/C10H18ClN3O7/c1-20-9-8(17)7(16)6(15)5(21-9)4-12-10(18)14(13-19)3-2-11/h5-9,15-17H,2-4H2,1H3,(H,12,18)
InChI KeyAHHFEZNOXOZZQA-ZEBDFXRSSA-N
SMILESCOC1C(C(C(C(O1)CNC(=O)N(CCCl)N=O)O)O)O
SolubilitySoluble in DMSO, not in water
SynonymsMCNU, methyl 6-((((2-chloroethyl)nitrosoamino)carbonyl) amino)-6-deoxy-alpha-D-glucopyranoside, methyl 6-(3-(2-chloroethyl)-3-nitrosoiureido)-6-deoxy-alpha-D-glucopyranoside, methyl 6-(3-(2-chloroethyl)-3-nitrosoureido)-6-deoxy-alpha-D-glucopyranoside, ranimustine, ranimustine, (beta)-(D)-isomer
Canonical SMILESCOC1C(C(C(C(O1)CNC(=O)N(CCCl)N=O)O)O)O
Isomeric SMILESCO[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CNC(=O)N(CCCl)N=O)O)O)O


在线询价

用手机扫描二维码关闭
二维码